Skip to main content

Gamma-Butyrolactone (Prohibition)

Volume 481: debated on Tuesday 28 October 2008

I beg to move,

That leave be given to bring in a Bill to provide for the classification of gamma-butyrolactone as a Class C drug under the Misuse of Drugs Act 1971; and for connected purposes.

I know from conversations with the Roofie Foundation, Europe’s only drug-assisted rape agency, that there are date rape victims in my constituency, and many other Members—indeed, far too many—will find that the same applies in their constituencies.

The Government have already taken firm action to tackle date rape. The Sexual Offences Act 2003 formally acknowledged it as a crime, and made it an offence punishable by up to 10 years in prison to administer any stupefying substance with the intent of overpowering the victim in order to engage him or her in sexual activity. Over the past few years, the Government have also outlawed the most commonly used date-rape drugs. I refer in particular to ketamine, Rohypnol and gamma-hydroxybutyric acid. I welcome that action, and urge the Government to continue in the same vein with gamma-butyrolactone, or GBL as it is more commonly known. GBL is an industrial solvent, and is a common component in cleaning products. Although it does have legitimate uses, it is increasingly being used to facilitate date rape, and as a recreational drug. In fact, as the Advisory Council on the Misuse of Drugs points out, there is evidence that it is precisely because GHB was outlawed that we have seen an increase in the use of GBL, with users switching to an almost identical, but entirely legal, alternative. Indeed, as GHB has already been banned and GBL turns into GHB on ingestion, there is already an a priori case for extending that ban to GBL.

The precise effects of GBL will, of course, vary according to the user and the dose taken, but it is likely to leave the victim confused, dazed, drowsy, and even unconscious, thereby rendering them incapable of resisting sexual advances. These effects may occur within as little as 15 minutes, and can last for up to 8 hours. It is also a popular choice of drug because it is so difficult to spot. When dissolved in soft drinks, beers and spirits, it is colourless, odourless, invisible and indiscernible in taste. GBL is undetectable in blood and urine after 10 to 12 hours. Not only is it, therefore, difficult for the victim to spot, but it is difficult to trace once the attack has taken place.

It is precisely because it is so difficult to prosecute for date rape and secure convictions that the law needs to be used to prevent drugs such as GBL from being available. At present, the police have no power to confiscate GBL, and clubs cannot say to a customer, “We know that liquid is illegal and we are calling the police”. They can act only when an offence involving GBL has been committed, but, unfortunately, this is often too late—not only too late in terms of the chances of securing a conviction, but, more importantly, too late for the women themselves.

Although my remarks today will focus on the dangers of GBL when used in the commission of date rape, its use is by no means limited to that. It is also widely used as a recreational drug, particularly on the clubbing scene, where it is considered a kind of cheaper liquid ecstasy. Although it can induce feelings of euphoria and disinhibition, its effects are most certainly not benign, and it has been implicated in two deaths in the past month alone. Such loss of life is avoidable, and if the Government are serious about tackling date rape, as I believe they have shown themselves to be, it is essential that this loophole is closed as a matter of urgency.

In fact, the Government accept that case. In 2006, the Home Office asked the Advisory Council on the Misuse of Drugs—the independent body whose role is to advise Government on drug control in the UK—to look into GBL, and its response was unambiguous: GBL should be brought under the control of the Misuse of Drugs Act 1971, and classified as a class C drug. Such a proposal, moreover, commands cross-party support; my Bill has sponsors from across the House. It also has the backing of the experts in this area; my Bill is supported by the Advisory Council on the Misuse of Drugs, the Roofie Foundation and nightclubs themselves. It also enjoys popular support, as evidenced by the number of people who have signed up to the petition launched by Cosmopolitan magazine. However, despite the recommendations of the Advisory Council on the Misuse of Drugs, two years on GBL is still perfectly legal.

The question therefore is not why GBL should be prohibited, but why GBL has not already been outlawed. My fear is that GHB and GBL are not only chemically similar, but that they will follow a similarly protracted route to prohibition. It was in the early 1990s that people first became aware of GHB, and in particular of its use in cases of date rape, but it was not outlawed until 2003; in other words, that took a decade, and a plethora of reports and consultations, all of which confirmed that GHB should be a controlled substance.

Two years have already passed since the Advisory Council on the Misuse of Drugs first recommended GBL’s prohibition, and it is still perfectly legal to supply GBL. It is quick and straightforward and frighteningly easy to buy GBL, particularly online. In addition, as the recent report in Cosmopolitan highlighted, there are no checks or controls on its purchase. At £25 for 250 ml, it is also extremely cheap, with an active dose costing somewhere in the region of 8p. Meanwhile, an untold number of women are put at risk.

As I understand it, the principal obstacle blocking the prohibition of GBL is its legitimate use, particularly in the manufacturing and chemical industries. I do not seek to deny that GBL has legitimate uses, and I accept that it is widely used as an industrial solvent. What I find difficult to believe, however, is that an industrial solvent being sold in bottles of 250 ml to private citizens in central London, with same-day delivery, is actually being used for legitimate industrial purposes.

What needs to happen, and what my Bill provides for, is an end to the open market for GBL. At the moment anyone can buy it for any purpose, without having to specify that purpose. My Bill would make GBL a controlled substance under the 1971 Act, but that would not mean that it could not be used for legitimate purposes. All that would be required of those who needed GBL for legitimate purposes would be to make an application to the relevant authorities. The provisions for that are contained in the 1971 Act itself. That is precisely how GBL is managed in the United States, which has classified it as a schedule 1 drug without precipitating the collapse of its chemical industry. That GBL has legitimate uses is no excuse for inaction.

Yesterday, I spoke to a young woman, 22 years of age and a victim of these substances. Her drink was spiked and she suffered a 25-minute seizure. It was only thanks to the skill of the doctors and nurses who treated her that she survived at all. Her health is poor and she now needs to use a wheelchair. The consequences for her will last a lifetime.

The case for the prohibition of GBL is clear. It would protect women without putting unnecessary burdens on its legitimate use. I only hope that we address this problem now, before any more victims without redress are created.

Question put and agreed to.

Bill ordered to be brought in by Joan Ryan, Bob Spink, Mr. Elfyn Llwyd, Mr. Lee Scott, David Cairns, Mr. John Leech, Mr. Mike Hancock, Siobhain McDonagh, Liz Blackman and Julie Morgan.

Gamma-Butyrolactone (prohibition)

Joan Ryan accordingly presented a Bill to provide for the classification of gamma-butyrolactone as a Class C drug under the Misuse of Drugs Act 1971; and for connected purposes: And the same was read the First time; and ordered to be read a Second time on Friday 7 November, and to be printed [Bill 156].